Loading...

Henry Schein, Inc.

HSICNASDAQ
Healthcare
Medical - Distribution
$71.46
$-1.16(-1.60%)

Henry Schein, Inc. (HSIC) Stock Overview

Explore Henry Schein, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.1/100

Key Financials

Market Cap8.7B
P/E Ratio21.71
EPS (TTM)$3.21
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Week$68.09
1 Month$67.01
3 Months$70.11
1 Year Target$67.78

HSIC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Henry Schein, Inc. (HSIC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $67.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.71 and a market capitalization of 8.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;